Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogenic alterations in advanced NSCLC: a molecular super-highway
Alex Friedlaender, M. Pérol, Giuseppe Luigi Banna, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4189-4189
Open Access | Times Cited: 10
Same‐day molecular testing for targetable mutations in solid tumor cytopathology—The next frontier of the rapid on‐site evaluation
J. Bryan Iorgulescu, Richard K. Yang, Sinchita Roy‐Chowdhuri, et al.
Cancer Cytopathology (2025) Vol. 133, Iss. 1
Open Access | Times Cited: 1
The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer
Barbara Melosky, Rosalyn A. Juergens, Shantanu Banerji, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer
Haowei Wang, Lei Cheng, Jian Chen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Genomic profiling of driver gene alterations in patients with non-small cell lung cancer, patterns of treatment and impact on survival outcomes – A single center experience of more than 1200 patients
Minit Shah, Vanita Noronha, Vijay Patil, et al.
Clinical Lung Cancer (2025)
Closed Access
Hsa_circ_0000515 sequesters microRNA‐296‐5p and elevates RNF44 expression to encourage the NSCLC progression
Lixin Sun, Bei Lü, Chongyuan Li, et al.
Journal of Cell Communication and Signaling (2025) Vol. 19, Iss. 1
Open Access
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer
Martin Sattler, Ravi Salgia
Cell Reports Medicine (2025), pp. 101983-101983
Open Access
Reagentless aptamer based on the ultrasensitive and fast response electrochemical capacitive biosensor for EGFR detection in non-small cell lung cancer
Enkhzaya Ganbold, Nam‐Young Kim, Yu Mi Kim, et al.
Biosensors and Bioelectronics (2025) Vol. 278, pp. 117319-117319
Closed Access
Real-World Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the US
Divyan Chopra, David Waterhouse, Ihtisham Sultan, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 151-151
Open Access
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study
Alper Topal, Goncagül Akdağ, Sedat Yıldırım, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 490-490
Open Access
Novel strategies for rare oncogenic drivers in non-small-cell lung cancer: An update from the 2024 Annual ESMO meeting
Tijmen J.W.T. van der Wel, Adrianus J. de Langen
Lung Cancer (2025), pp. 108490-108490
Closed Access
RASON promotes KRASG12C-driven tumor progression and immune evasion in non-small cell lung cancer
Jianzhuang Wu, Kexin Xie, Yixuan Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging Applications
Laurenţia Galeş, Mihai-Andrei Păun, Ioana Butnariu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3123-3123
Open Access
Real-World Performance of the EasyPGX® Ready Epidermal Growth Factor Receptor Assay for Genomic Testing of Non-Small Cell Lung Cancer Samples
Michael B. Schmid, Izadora Demmer, Sandra Floriani, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 814-814
Open Access
Update advances in anaplastic lymphoma kinase‐positive non–small cell lung cancer treatment
B. Munárriz, Sam Khan, Y Q Li, et al.
Cancer (2025) Vol. 131, Iss. S1
Closed Access
Landscape and clinical implications of EGFR exon 20 insertions in non-small cell lung cancer patients
Mónica Garzón‐Ibáñez, Roxana Reyes, Miguel Ángel Molina‐Vila, et al.
Clinical & Translational Oncology (2025)
Closed Access
The future of tumor organoids in precision therapy
Seok-Young Kim, Marc van de Wetering, Hans Clevers, et al.
Trends in cancer (2025)
Open Access
Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer
Motohiro Izumi, Daniel B. Costa, Susumu Kobayashi
Lung Cancer (2024) Vol. 194, pp. 107885-107885
Closed Access | Times Cited: 3
The Causal Effect of Gut Microbiota and Plasma Metabolome on Lung Cancer and the Heterogeneity across Subtypes: A Mendelian Randomization Study
Jun Zeng, Bin Yi, Ruimin Chang, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 453-453
Open Access | Times Cited: 2
Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer
Hongyan Li, Lina Xu, Hongshun Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Therapeutic Efficacy of Nanocarrier‐Mediated Inhalable Gene Transfection for Lung Cancer
Poulami Sarkar, M. Rizwan Sardar, Olivia Sen, et al.
ChemistrySelect (2024) Vol. 9, Iss. 37
Closed Access | Times Cited: 2
Contemporary Concise Review 2023: Advances in lung cancer and interventional pulmonology
Tracy L. Leong, Daniel P. Steinfort
Respirology (2024) Vol. 29, Iss. 8, pp. 665-673
Open Access | Times Cited: 1
Targeting ALK receptors in non-small cell lung cancer: what is the road ahead?
P. Maione, Vincenzo Palma, Giuseppina Pucillo, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 659-668
Closed Access | Times Cited: 1
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer
Se‐Hoon Lee, Jessica Menis, T.M. Kim, et al.
ESMO Open (2024) Vol. 9, Iss. 12, pp. 103996-103996
Closed Access | Times Cited: 1
Genomic and computational-aided integrative drug repositioning strategy for EGFR and ROS1 mutated NSCLC
Varsha Tripathi, Aishwarya Khare, Divyanshi Shukla, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112682-112682
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top